Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine alone versus desloratadine + fluticasone nasal spray for pediatric allergic rhinitis
ISRCTN25497748Phase 4Completed
- Sponsor
- Affiliated Huai'an Hospital of Xuzhou Medical University
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of desloratadine and fluticasone propionate in allergic rhinitis (AR) (2 arms), sponsored by Affiliated Huai'an Hospital of Xuzhou Medical University. Started Dec 2023; status: completed.
02
Drugs
desloratadinefluticasone propionate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ISRCTN25497748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN25497748.